PhaseWell and LCTC to expand clinical trial access in Puerto Rico

PhaseWell Research has partnered with Latin Clinical Trial Center (LCTC) in Puerto Rico to broaden clinical trial access within the region. The collaboration is part of PhaseWell’s initiative to increase trial participation by linking community practices and US sites. PhaseWell reports having completed over 2,285 clinical trials and contributed to more than 195 therapy approvals. Credit: PeopleImages / Shutterstock.com. PhaseWell Research has entered a partnership with Latin Clinical Trial Center (LCTC) in San Juan, Puerto Rico, to broaden access to clinical trials within the region. Led by founder and principal investigator Dr Carlos Sariol and site leader Anmari Ferrer, LCTC…

Source: Clinical Trials Arena